[{"data":1,"prerenderedAt":364},["ShallowReactive",2],{"story-5938-en":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":61,"questions":62,"relatedArticles":72,"body_color":362,"card_color":363},"5938",null,"Oral GLP-1 Drugs: Transforming Obesity Treatment and Pharmaceutical Market Dynamics","- FDA Approval Signals Massive Shift in Weight Loss Medication Accessibility and Market Potential",[],[10,11,12,13,14,15,16,17,18,19,20,21,18,22,23,24,25,26,27,28,29,30,31,32,33,33,18,34,35,36,37,38,39,28,40,41,42,43,44,45,46,47,48,49,18,50,51,52,53,54,55,56,57,58,59,11,60],"https://www.reuters.com/resizer/v2/K7LR2TQLGJLQHCLP75YU2NBRHI.jpg?auth=2821050d6200071b6490f8f593cd1043cdc965557a7bfb9f6a1f611caf6a76bd&width=1200&quality=80","https://images.wsj.net/im-03578447?width=700&height=466","https://assets.newsweek.com/wp-content/uploads/2025/12/GettyImages-656593484.jpg?w=1600&h=900&q=88","https://i.insider.com/694a2d4b04eda4732f2e05d5?width=700","https://bloximages.newyork1.vip.townnews.com/thederrick.com/content/tncms/assets/v3/editorial/b/70/b70fa6fe-23da-56b5-b9fa-208ea8acd5cc/6938a0905e11e.image.jpg?resize=400%2C267","https://storage.googleapis.com/media.mwcradio.com/mimesis/2025-12/22/2025-12-22T225956Z_2_LYNXMPELBL0X8_RTROPTP_3_NOVO-NORDISK.JPG","https://cdn.sanity.io/images/0vv8moc6/act/5d15840958801fc7c4674c35f18df518575e8843-1080x1080.png?w=300&fit=crop&auto=format","https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg","https://static.gurufocus.com/cdn-cgi/image/width=500,quality=100/logos/0C00000BWS.png?20","https://www.investors.com/wp-content/uploads/2025/11/NEWAM_pills_112825_adobe.jpg","https://static.independent.co.uk/2023/06/26/02/Obesity_Pill_72947.jpg","https://cdn.sanity.io/images/0vv8moc6/ajmc/1a45ef176138b54155bc90e8100eb2e385d4db50-1200x738.jpg","https://media.cnn.com/api/v1/images/stellar/prod/115984-fdaapproveswegovy-16x9-clean-thumb.jpg?c=original","https://www.israelhayom.com/wp-content/uploads/2025/12/getty-images_getty-imagesistockphoto-960x640-1200px.jpg","https://www.statnews.com/wp-content/uploads/2025/12/GettyImages-2245790195-645x645.jpg","https://images.ladbible.com/resize?type=webp&quality=70&width=3840&fit=contain&gravity=auto&url=https://images.ladbiblegroup.com/v3/assets/bltb5d92757ac1ee045/blt712ef71dc753d2ec/69453cb746605875bd7abd13/ozempic-coming-in-pill-form.png%3Fcrop%3D675%2C675%2Cx301%2Cy0","https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","https://endpoints.news/wp-content/uploads/2025/11/Novo-Nordisk-HQ-AP-social1.jpg","https://ichef.bbci.co.uk/news/1024/branded_news/af6b/live/bcb57630-df97-11f0-aae2-2191c0e48a3b.jpg","https://media.wltx.com/assets/WLTX/images/8278c888-6ced-4cea-ac95-d8601c8f3f24/20251223T042006/8278c888-6ced-4cea-ac95-d8601c8f3f24_1920x1080.jpg","https://bostonglobe-prod.cdn.arcpublishing.com/resizer/v2/TIC3E3ZSNMUBIGM7EZ66TMLTXM.jpg?auth=ba5ed0b1dacdfc47c4a49fe933a16c0b7971f747748bfc2d87c690947344b186&width=1440","https://cdn.sanity.io/images/0vv8moc6/pharmexec/ab965ea0a889f2c2a2a31157d46dc13fdc90c31e-1280x720.png?w=1280&max-h=720&fit=crop&auto=format","https://images.foxtv.com/static.livenowfox.com/www.livenowfox.com/content/uploads/2025/12/764/432/wegovy.jpg?ve=1&tl=1","https://www.geneonline.com/wp-content/uploads/EN_Mobile_Dec_HIV_AIDS-450x350.png","https://plib.aastocks.com/aafnnews/image/medialib/20250610165731701_l.jpg","https://i.guim.co.uk/img/media/bcdd3269111457b5b2d4a21da9c0c2b2039ca422/560_0_5600_4480/master/5600.jpg?width=465&dpr=1&s=none&crop=none","https://imageio.forbes.com/specials-images/imageserve/6949d38e96e032147927777e/DENMARK-HEALTH-PHARMACOLOGY-TECHNOLOGY/0x0.jpg?crop=3905,2606,x1,y0,safe&height=474&width=711&fit=bounds","https://npr.brightspotcdn.com/dims3/default/strip/false/crop/3377x1900+0+0/resize/1100/quality/50/format/jpeg/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2Fa5%2Fc5%2Fd4e4bab54e8c885617d9e73c2a83%2Fe63adfa6-19d2-4330-a39b-ee64944d143c.jpg","https://media.cnn.com/api/v1/images/stellar/prod/novo-nordisk-oral-semaglutide-25-mg-image-6.jpg?c=original&q=w_860,c_fill","https://res.cloudinary.com/graham-media-group/image/upload/f_auto/q_auto/d_https:::media.clickondetroit.com:theme:images:placeholder-16x9-wdiv.png/c_scale,w_640/v1/media/gmg/ZMLM4I3DK5CJLAACI2LUIE7I5Y.jpg?_a=DAJHqpE+ZAAA","https://news.stocktwits-cdn.com/large_Novo_Nordisk_jpg_96dd19f953.webp","https://image.cnbcfm.com/api/v1/image/108231152-17640105232025-11-24t185245z_617754530_rc263iabxpyr_rtrmadp_0_novo-nordisk.jpeg?v=1764010568&w=1600&h=900","https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iEM9sw6CRt6g/v1/-1x-1.webp","https://static.biospace.com/dims4/default/648b6d6/2147483647/strip/true/crop/622x350+2+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2Flegacy%2FBioSpace-Assets%2F83846946-7BEE-4E9F-87F1-92B625638D44.jpg","https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2158305454/image_2158305454.jpg?io=getty-c-w630","https://media-cldnry.s-nbcnews.com/image/upload/t_fit-560w,f_auto,q_auto:best/rockcms/2025-11/251126-Novo-Nordisk-weight-loss-pill-ew-1115a-81fc49.jpg","https://images.axios.com/0se-IkZtecgFws5yutuw5fPQDXo=/1920x1080/smart/2022/12/09/181408-1670609648504.jpg","https://ml-eu.globenewswire.com/Resource/Download/18c2fb08-e2c1-4a52-90dd-5c0f18213eb6?size=2","https://www.devdiscourse.com/remote.axd?https://devdiscourse.blob.core.windows.net/aiimagegallery/19_08_2025_12_57_50_5687556.png?width=1280","https://s.abcnews.com/images/Health/wirestory_dd32754cc0c388822378e4a9411843e9_16x9_1600.jpg","https://kubrick.htvapps.com/htv-prod-media.s3.amazonaws.com/images/uab-6949e89ea2ad6.jpg?crop=0.784xw:0.783xh;0.104xw,0&resize=900:*","https://mezha.net/wp-content/uploads/2025/12/22/fda-approves-oral-wegovy.webp","https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1643811377/NovoNordisk.jpg/NovoNordisk.jpg?VersionId=V.pw8CspHXDv3nI_lOsm3AS38U4gC1BA","https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iRhoB1YSjlEw/v0/-1x-1.webp","https://static01.nyt.com/images/2025/12/22/multimedia/HFO-WEGOVY-PILL/HFO-WEGOVY-PILL-articleLarge.jpg?quality=75&auto=webp&disable=upscale","https://media.wired.com/photos/6941334fb871f460797b4951/master/w_2560%2Cc_limit/Novo%2520Nordisk%2520oral%2520semaglutide%252025%2520mg_image%25201.jpg","https://thehill.com/wp-content/uploads/sites/2/2025/08/AP25017530029403-e1754150421371.jpg?strip=1","https://www.theglobeandmail.com/resizer/v2/WHR777OOWNCWBJSWWCWV54EUMM.jpg?auth=da586122fe330fc467965b36641db8971d8c07275a3c793431f767a4955784a8&width=1200&height=800&quality=80&smart=true","https://bdc2020.o0bc.com/wp-content/uploads/2025/12/RSV_Drugs_FDA_65858-6938a45308a3f-768x432.jpg","https://images.wsj.net/im-34062673/social","https://imgproxy.divecdn.com/aeFXnLFdj2NUsapG_cmn6BWHi-Ou4uC6Q5thPHqMpNs/g:ce/rs:fill:1200:675:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzE1NjQ5MjUyLmpwZw==.webp","The emergence of oral **GLP-1 medications** represents a pivotal moment in pharmaceutical innovation, fundamentally reshaping the obesity treatment landscape. With **Novo Nordisk's** groundbreaking FDA approval, the weight loss drug market is poised for a transformative leap, signaling a strategic inflection point that extends far beyond traditional injectable treatments.\n\n**Regulatory compliance** and **patient accessibility** are driving this revolutionary shift. The new oral **semaglutide** pill addresses multiple critical barriers that previously limited weight loss medication adoption. Approximately 1 in 8 U.S. adults are already using GLP-1 medications, but the introduction of an oral alternative could dramatically expand this market. Clinical trials demonstrate remarkable efficacy, with patients losing an average of 14-16.6% body weight over 64 weeks—a substantial improvement over previous treatment modalities.\n\nThe market potential is staggering. Wall Street analysts project the weight loss drug market could reach **$100 billion by the 2030s**, with oral pills potentially capturing a **24% market share** (approximately $22 billion). This isn't just a pharmaceutical breakthrough; it's a comprehensive reimagining of obesity treatment that combines medical innovation with consumer convenience.\n\nBeyond weight loss, these medications are revealing promising secondary health benefits, including reduced cardiac disease risk, improved sleep apnea outcomes, and enhanced liver function. The oral format addresses critical patient concerns about injection discomfort, complex administration, and high monthly costs (previously over $1,000 for injectable versions).\n\nCompetitive dynamics are also rapidly evolving. **Novo Nordisk** has positioned itself ahead of competitors like **Eli Lilly** by securing early FDA approval, creating a significant first-mover advantage in this emerging market. The strategic implications extend beyond the immediate product—this represents a fundamental shift in how pharmaceutical companies approach chronic condition management.\n\nFor cross-border e-commerce and healthcare markets, this development signals substantial opportunities. The emergence of more accessible obesity treatment options could expand market demand and create new product niches, particularly in wellness and pharmaceutical categories.",[63,66,69],{"title":64,"answer":65,"author":5,"avatar":5,"time":5},"What makes these new oral GLP-1 medications different from previous treatments?","Unlike previous injectable medications costing over $1,000 monthly, these oral pills offer more convenient administration, similar weight loss efficacy (14-16.6% body weight reduction), and potentially lower costs. They also demonstrate additional health benefits beyond weight loss, including reduced cardiac and metabolic risks.",{"title":67,"answer":68,"author":5,"avatar":5,"time":5},"What are the potential market implications for healthcare and wellness industries?","The oral GLP-1 medications create new opportunities in pharmaceutical, wellness, and e-commerce markets. They signal a shift towards more accessible chronic condition management, potentially expanding market demand and creating novel product niches for international healthcare and wellness sellers.",{"title":70,"answer":71,"author":5,"avatar":5,"time":5},"How significant is the FDA approval of oral GLP-1 medications?","The FDA approval is transformative, potentially expanding the weight loss drug market from current injectable formats to a more accessible oral medication. Wall Street predicts this could represent a $22 billion market opportunity by the 2030s, with oral pills capturing approximately 24% market share.",[73,78,82,86,90,94,98,102,106,110,114,117,121,125,129,133,137,141,145,149,153,158,162,166,170,174,177,180,184,188,192,196,200,204,209,213,217,221,225,228,231,235,238,242,246,250,254,258,262,266,270,273,277,281,285,288,292,296,299,302,307,311,315,318,323,326,330,333,337,341,345,349,353,356,359],{"id":74,"title":75,"source":76,"logo":54,"time":77},133467,"F.D.A. Approves Wegovy Weight-Loss Pill","https://www.nytimes.com/2025/12/22/well/fda-approves-wegovy-weight-loss-pill.html","3D AGO",{"id":79,"title":80,"source":81,"logo":5,"time":77},134479,"Novo Nordisk wins US approval for weight-loss pill","https://finance.yahoo.com/news/novo-nordisk-wins-us-approval-225956288.html",{"id":83,"title":84,"source":85,"logo":18,"time":77},133468,"NVO Surges 8% Following FDA Approval of Wegovy for Weight Loss","https://www.gurufocus.com/news/4080735/nvo-surges-8-following-fda-approval-of-wegovy-for-weight-loss",{"id":87,"title":88,"source":89,"logo":19,"time":77},133469,"Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug","https://www.investors.com/news/technology/novo-nordisk-stock-jumps-fda-oks-wegovy-pill-first-oral-glp-1-weight-loss-drug/",{"id":91,"title":92,"source":93,"logo":57,"time":77},133463,"Eli Lilly, Novo Nordisk to benefit from new obesity treatments in 2026","https://www.theglobeandmail.com/investing/markets/inside-the-market/article-2026-the-year-of-obesity-treatments/",{"id":95,"title":96,"source":97,"logo":55,"time":77},134475,"FDA Approves Pill Version of Wegovy","https://www.wired.com/story/fda-approves-pill-version-of-wegovy/",{"id":99,"title":100,"source":101,"logo":5,"time":77},133464,"Novo Nordisk's Wegovy Approved in China to Reduce Heart Risk - BN","https://www.marketscreener.com/news/novo-nordisk-s-wegovy-approved-in-china-to-reduce-heart-risk-bn-ce7d50d2df8afe25",{"id":103,"title":104,"source":105,"logo":52,"time":77},134476,"Novo Nordisk wins FDA approval for Wegovy in a pill, introducing first oral GLP-1 option for obesity","https://www.fiercepharma.com/pharma/novo-nordisk-wins-fda-approval-wegovy-pill-introducing-first-oral-glp-1-option-obesity",{"id":107,"title":108,"source":109,"logo":27,"time":77},133465,"Novo Nordisk eyes a strong launch with FDA approval of obesity pill","https://endpoints.news/novo-nordisk-eyes-a-strong-launch-with-fda-approval-of-obesity-pill/",{"id":111,"title":112,"source":113,"logo":11,"time":77},134477,"Pill Version of Wegovy Is Approved for Use in the U.S.","https://www.wsj.com/health/pharma/pill-version-of-wegovy-is-approved-for-use-in-the-u-s-6d6a6f2d?gaa_at=eafs&gaa_n=AWEtsqfLQqkMCYrIqq197RuKCZBZgkf75xOvpvoqcRn6vaGVPNb3YC3xEj7u&gaa_ts=694a188f&gaa_sig=2yAIOZ6_mVcVEQoszUbyrJ4xYuPHK6mlJ-o433fqmGVUlKA7ZCLtYhrZB4TQsuvuXOO6NOiHdwGt76m-RWe1iQ%3D%3D",{"id":115,"title":80,"source":116,"logo":15,"time":77},133466,"https://kfgo.com/2025/12/22/novo-nordisk-wins-us-approval-for-weight-loss-pill/",{"id":118,"title":119,"source":120,"logo":5,"time":77},134478,"FDA approves Wegovy weight loss pill from Novo Nordisk","https://www.yahoo.com/news/articles/fda-approves-wegovy-weight-loss-232450508.html",{"id":122,"title":123,"source":124,"logo":18,"time":77},135609,"Novo Nordisk (NVO) Gains as FDA Approves Oral Wegovy for Obesity","https://www.gurufocus.com/news/4080745/novo-nordisk-nvo-gains-as-fda-approves-oral-wegovy-for-obesity",{"id":126,"title":127,"source":128,"logo":39,"time":77},135608,"US regulators approve Wegovy pill for weight loss","https://www.clickondetroit.com/business/2025/12/23/us-regulators-approve-wegovy-pill-for-weight-loss/",{"id":130,"title":131,"source":132,"logo":5,"time":77},135607,"FDA approves Wegovy weight-loss pill from Novo Nordisk","https://www.cincinnati.com/story/news/health/2025/12/22/wegovy-fda-approval-weight-loss-pill-novo-nordisk/87889650007/",{"id":134,"title":135,"source":136,"logo":18,"time":77},133470,"Novo Nordisk (NVO) Gains U.S. Approval for Oral Wegovy Pill","https://www.gurufocus.com/news/4080737/novo-nordisk-nvo-gains-us-approval-for-oral-wegovy-pill",{"id":138,"title":139,"source":140,"logo":18,"time":77},133471,"Novo Nordisk (NVO) Gains FDA Approval for Wegovy Pill in Weight Management","https://www.gurufocus.com/news/4080734/novo-nordisk-nvo-gains-fda-approval-for-wegovy-pill-in-weight-management",{"id":142,"title":143,"source":144,"logo":46,"time":77},133472,"FDA approves first GLP-1 pill for weight loss","https://www.axios.com/2025/12/22/fda-weight-loss-pill-glp-1-approved",{"id":146,"title":147,"source":148,"logo":12,"time":77},133473,"First-Ever GLP-1 Obesity Pill Approved by FDA","https://www.newsweek.com/first-ever-glp-1-obesity-pill-approved-by-fda-11257650",{"id":150,"title":151,"source":152,"logo":51,"time":77},133478,"FDA Approves Oral Wegovy Pill for Obesity Treatment","https://mezha.net/eng/bukvy/fda-approves-oral-wegovy-pill-for-obesity-treatment/",{"id":154,"title":155,"source":156,"logo":42,"time":157},135613,"Novo Nordisk Gets US Approval for Wegovy Obesity Pill","https://www.bloomberg.com/news/newsletters/2025-12-23/novo-nordisk-gets-us-approval-for-wegovy-obesity-pill","2D AGO",{"id":159,"title":160,"source":161,"logo":48,"time":77},133479,"Novo Nordisk's New Weight-Loss Breakthrough: A Game-Changer in Obesity Management","https://www.devdiscourse.com/article/technology/3739175-novo-nordisks-new-weight-loss-breakthrough-a-game-changer-in-obesity-management",{"id":163,"title":164,"source":165,"logo":13,"time":157},135612,"A cheaper, easier-to-use version of Wegovy is coming to the US soon","https://www.businessinsider.com/wegovy-pill-approved-us-cheap-injections-glp1-weight-loss-2025-12",{"id":167,"title":168,"source":169,"logo":5,"time":157},135615,"Novo's Wegovy Pill to Test Demand From Consumers With Cash","https://www.usnews.com/news/top-news/articles/2025-12-23/novos-wegovy-pill-to-test-demand-from-consumers-with-cash",{"id":171,"title":172,"source":173,"logo":5,"time":157},135614,"FDA Approves First Daily Wegovy Pill for Long-Term Weight Management","https://southfloridareporter.com/fda-approves-first-daily-wegovy-pill-for-long-term-weight-management/",{"id":175,"title":80,"source":176,"logo":10,"time":77},133474,"https://www.reuters.com/sustainability/boards-policy-regulation/novo-nordisk-wins-us-approval-weight-loss-pill-2025-12-22/",{"id":178,"title":119,"source":179,"logo":45,"time":77},133672,"https://www.nbcnews.com/health/health-news/fda-approves-wegovy-weight-loss-pill-novo-nordisk-rcna240800",{"id":181,"title":182,"source":183,"logo":33,"time":77},133475,"FDA Approves First Oral Version of Novo Nordisk’s Obesity Drug Wegovy","https://www.geneonline.com/fda-approves-first-oral-version-of-novo-nordisks-obesity-drug-wegovy/",{"id":185,"title":186,"source":187,"logo":38,"time":77},133673,"With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins","https://www.cnn.com/2025/12/22/health/wegovy-pill-glp1-weight-loss-drugs",{"id":189,"title":190,"source":191,"logo":44,"time":77},133476,"Novo Nordisk rises as FDA approves Wegovy pill for obesity","https://seekingalpha.com/news/4534514-novo-nordisk-rises-fda-approves-wegovy-pill-obesity",{"id":193,"title":194,"source":195,"logo":41,"time":77},133674,"FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk","https://www.cnbc.com/2025/12/22/fda-approves-first-glp-1-pill-for-obesity-from-novo-nordisk.html",{"id":197,"title":198,"source":199,"logo":23,"time":157},135611,"FDA approves pill version of popular weight loss injection","https://www.israelhayom.com/2025/12/23/fda-approves-pill-version-of-popular-weight-loss-injection/",{"id":201,"title":202,"source":203,"logo":36,"time":77},133477,"FDA Approves Pill Version Of Novo Nordisk’s Wegovy—A First For GLP-1s","https://www.forbes.com/sites/antoniopequenoiv/2025/12/22/fda-approves-pill-version-of-novo-nordisks-wegovy-a-first-for-glp-1s/",{"id":205,"title":206,"source":207,"logo":37,"time":208},133675,"GLP-1 pills are on the way. Here's what to know : Short Wave","https://www.npr.org/2025/12/19/nx-s1-5642950/diabetes-ozempic-pill-glp","6D AGO",{"id":210,"title":211,"source":212,"logo":5,"time":77},135610,"FDA approves oral version of weight-loss drug semaglutide, UAB researchers react","https://www.uab.edu/news/research-innovation/fda-approves-oral-version-of-weight-loss-drug-semaglutide-uab-researchers-react",{"id":214,"title":215,"source":216,"logo":28,"time":77},135617,"Wegovy pill approved by US FDA for weight loss","https://www.bbc.com/news/articles/ce86le5dyxyo",{"id":218,"title":219,"source":220,"logo":29,"time":157},135616,"FDA approves Wegovy pill for weight loss","https://www.wltx.com/video/news/nation-world/fda-approves-wegovy-pill-for-weight-loss/101-f95e049b-b386-404b-ae11-d8957eaaa598",{"id":222,"title":223,"source":224,"logo":24,"time":77},133481,"FDA approves pill version of Novo Nordisk’s Wegovy, possibly widening access","https://www.statnews.com/2025/12/22/wegovy-pill-oral-weight-loss-treatment-approved/",{"id":226,"title":112,"source":227,"logo":11,"time":77},133482,"https://www.wsj.com/health/pharma/pill-version-of-wegovy-is-approved-for-use-in-the-u-s-6d6a6f2d?gaa_at=eafs&gaa_n=AWEtsqd49gbWk6bCK1sT_Y4bfFjmx3yojqF-B46HYrFJKJHVI6duScaFv5z_&gaa_ts=6949e05b&gaa_sig=mTGa7pBU3l85hGR-Hqhz0yxfgfB6Ml-yQsDqLNaNvy2f_gc6MMVdf5HAqHlpbDRM1p0IsJnfMrta-JRysoObWA%3D%3D",{"id":229,"title":155,"source":230,"logo":53,"time":77},133483,"https://www.bloomberg.com/news/articles/2025-12-22/novo-nordisk-gets-us-approval-for-wegovy-obesity-pill",{"id":232,"title":233,"source":234,"logo":5,"time":77},133484,"Novo Nordisk stock soars after FDA approves first oral GLP-1 for weight loss","https://www.investing.com/news/stock-market-news/novo-nordisk-stock-soars-after-fda-approves-first-oral-glp1-for-weight-loss-4420411",{"id":236,"title":80,"source":237,"logo":5,"time":77},133480,"https://ca.finance.yahoo.com/news/novo-nordisk-wins-us-approval-231202989.html",{"id":239,"title":240,"source":241,"logo":5,"time":77},133489,"Lilly vs Novo Nordisk. Why 2026 Could Redefine the Obesity Drug Market","https://finance.yahoo.com/news/lilly-vs-novo-nordisk-why-142301216.html",{"id":243,"title":244,"source":245,"logo":21,"time":77},134457,"FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss","https://www.ajmc.com/view/fda-approves-oral-semaglutide-as-first-glp-1-pill-for-weight-loss",{"id":247,"title":248,"source":249,"logo":5,"time":77},134458,"FDA approves oral version of Wegovy","https://www.yahoo.com/news/articles/fda-approves-oral-version-wegovy-005840728.html",{"id":251,"title":252,"source":253,"logo":34,"time":77},134459,"Novo Nordisk Soars 10% Post-Mkt as Oral Weight Loss Drug Receives FDA Approval","https://www.aastocks.com/en/usq/news/comment.aspx?source=AAFN&id=NOW.1491989&catg=4",{"id":255,"title":256,"source":257,"logo":5,"time":77},133485,"Novo Nordisk Wins US Approval for Weight-Loss Pill","https://www.usnews.com/news/us/articles/2025-12-22/novo-nordisk-wins-us-approval-for-weight-loss-pill",{"id":259,"title":260,"source":261,"logo":47,"time":77},133486,"Novo Nordisk A/S: Wegovy® pill approved in the US as first oral GLP-1 for weight management","https://www.globenewswire.com/news-release/2025/12/22/3209605/0/en/Novo-Nordisk-A-S-Wegovy-pill-approved-in-the-US-as-first-oral-GLP-1-for-weight-management.html",{"id":263,"title":264,"source":265,"logo":59,"time":77},133487,"Novo Nordisk Weight-Loss Pill Gets Approval","https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-12-22-2025/card/novo-nordisk-weight-loss-pill-gets-approval-Nx08sgSkYnEuAXVK1KwQ?gaa_at=eafs&gaa_n=AWEtsqdq8SIzxivDxaqO_8YTfTQlyvKHnRoYzJC0uie6AWddQ0CFyqu3gJLh&gaa_ts=6949e05b&gaa_sig=-7G5mqWE9B0rjprB4OUge46x4j7fQmCn9yl95UO0kpcmGlC_jNah7AazM_ECFnstTL0ugnvsOZuILnMgzHV87w%3D%3D",{"id":267,"title":268,"source":269,"logo":5,"time":77},133488,"Novo Nordisk wins the oral obesity race with FDA approval of Wegovy","https://firstwordpharma.com/story/6872720",{"id":271,"title":248,"source":272,"logo":56,"time":77},134456,"https://thehill.com/policy/healthcare/5660548-fda-approves-wegovy-weight-loss/",{"id":274,"title":275,"source":276,"logo":26,"time":208},133492,"Novo Nordisk (CPSE:NOVO B) Advances GLP 1 Pipeline and Leadership Reset","https://simplywall.st/stocks/dk/pharmaceuticals-biotech/cph-novo-b/novo-nordisk-shares/news/novo-nordisk-cpsenovo-b-advances-glp-1-pipeline-and-leadersh",{"id":278,"title":279,"source":280,"logo":32,"time":77},134460,"Wegovy pill for weight loss approved by FDA; 1st of its kind","https://www.fox9.com/news/wegovy-pill-weight-loss-approved-fda-1st-its-kind",{"id":282,"title":283,"source":284,"logo":16,"time":208},133493,"ACT Brief: Neutral Tech Adoption at Sites, Scaling Unstructured Data for eSource, and Novo Nordisk’s CagriSema NDA","https://www.appliedclinicaltrialsonline.com/view/neutral-tech-adoption-sites-scaling-unstructured-data-esource-novo-nordisk-cagrisema-nda",{"id":286,"title":127,"source":287,"logo":49,"time":77},134461,"https://abcnews.go.com/Business/wireStory/us-regulators-approve-wegovy-pill-weight-loss-128635936",{"id":289,"title":290,"source":291,"logo":5,"time":208},133494,"Novo Nordisk Files NDA for Next-Generation Obesity Drug CagriSema","https://finance.yahoo.com/news/novo-nordisk-files-nda-next-135900065.html",{"id":293,"title":294,"source":295,"logo":33,"time":77},134462,"FDA Approves Oral Version of Obesity Drug Wegovy Previously Available as Injection","https://www.geneonline.com/fda-approves-oral-version-of-obesity-drug-wegovy-previously-available-as-injection/",{"id":297,"title":290,"source":298,"logo":17,"time":208},133495,"https://www.zacks.com/stock/news/2806640/novo-nordisk-files-nda-for-next-generation-obesity-drug-cagrisema",{"id":300,"title":215,"source":301,"logo":28,"time":77},134463,"https://www.bbc.co.uk/news/articles/ce86le5dyxyo",{"id":303,"title":304,"source":305,"logo":40,"time":306},133490,"Novo Nordisk Stock Soars After Hours As FDA Greenlights Wegovy Pill For Weight Loss","https://stocktwits.com/news-articles/markets/equity/novo-nordisk-stock-soars-after-hours-as-fda-greenlights-wegovy-pill-for-weightloss/cLeFw1kREu2","5D AGO",{"id":308,"title":309,"source":310,"logo":25,"time":208},133491,"Ozempic in a completely different form could be on the way as soon as next year","https://www.uniladtech.com/science/news/ozempic-completely-different-form-potentially-on-the-way-627134-20251219",{"id":312,"title":313,"source":314,"logo":20,"time":77},134468,"FDA approves Wegovy weight-loss pill in first green-lit alternative to injectable GLP-1 drugs","https://www.the-independent.com/news/wegovy-weight-loss-pill-glp1-fda-b2889301.html",{"id":316,"title":131,"source":317,"logo":5,"time":77},134469,"https://www.usatoday.com/story/news/health/2025/12/22/wegovy-fda-approval-weight-loss-pill-novo-nordisk/87889650007/",{"id":319,"title":320,"source":321,"logo":43,"time":322},133496,"Novo Nordisk Files Combo Obesity Drug CagriSema For FDA Approval","https://www.biospace.com/fda/novo-nordisk-files-combo-obesity-drug-cagrisema-for-fda-approval","7D AGO",{"id":324,"title":127,"source":325,"logo":14,"time":77},134464,"https://www.thederrick.com/ap/business/us-regulators-approve-wegovy-pill-for-weight-loss/article_8e2a308a-40bc-57f0-ad34-0e134be6406a.html",{"id":327,"title":328,"source":329,"logo":31,"time":322},133497,"Novo Nordisk Submits NDA to FDA for CagriSema","https://www.pharmexec.com/view/novo-nordisk-submits-nda-fda-cagrisema",{"id":331,"title":127,"source":332,"logo":5,"time":77},134465,"https://www.yahoo.com/news/articles/us-regulators-approve-wegovy-pill-001829779.html",{"id":334,"title":335,"source":336,"logo":60,"time":322},133498,"The leading GLP-1 contenders in pharma’s race for an obesity pill","https://www.pharmavoice.com/news/glp-1-pharma-obesity-pill-drug-novo-viking-structure-lilly/808195/",{"id":338,"title":339,"source":340,"logo":5,"time":77},134466,"Closing Bell Movers: Novo Nordisk gains on Wegovy FDA update","https://www.tipranks.com/news/the-fly/closing-bell-movers-novo-nordisk-gains-on-wegovy-fda-update-thefly",{"id":342,"title":343,"source":344,"logo":22,"time":157},134467,"Approved weight loss pill can be swallowed instead of injected","https://www.cnn.com/2025/12/22/health/video/approved-weight-loss-pill-wegovy-can-be-swallowed-instead-of-injected-digvid",{"id":346,"title":347,"source":348,"logo":50,"time":77},134471,"Oral semaglutide approved by FDA for obesity treatment","https://www.wvtm13.com/article/oral-semaglutide-approved-by-fda-for-obesity-treatment/69843390",{"id":350,"title":351,"source":352,"logo":35,"time":77},134472,"US regulators approve Wegovy pill, first oral medication to treat obesity","https://www.theguardian.com/us-news/2025/dec/22/us-regulators-approve-wegovy-weight-loss-pill",{"id":354,"title":127,"source":355,"logo":30,"time":77},134473,"https://www.bostonglobe.com/2025/12/22/business/us-approve-wegovy-pill-weight-loss/",{"id":357,"title":127,"source":358,"logo":5,"time":77},134474,"https://pressofatlanticcity.com/life-entertainment/nation-world/wellness/article_602c2bf9-76ae-5191-9dcf-03ada16877af.html",{"id":360,"title":127,"source":361,"logo":58,"time":77},134470,"https://www.boston.com/news/health/2025/12/22/us-regulators-approve-wegovy-pill-for-weight-loss/","#480424ff","#4804244d",1766688111304]